Ingredient intelligence

Ceramide NP

Skin barrier · Ceramide NP · C34H67NO4

Ceramide NP is a sphingolipid found in the stratum corneum lipid matrix. Ceramide composition is a well-described feature of barrier biology.

Molecular identity

Two-dimensional chemical structure of Ceramide NP
Formula
C34H67NO4
Molecular weight
553.9 g/mol
PubChem CID
5497114
ChEBI
Data unavailable
Open PubChem record →

Biological targets

  • Ceramide synthase 3 (CERS3)

    medium confidence

    associated with · enzyme

    UniProt Q8IU89
  • ABCA12 lipid transporter

    medium confidence

    associated with · transporter

    UniProt Q86UK0

Molecules & genes

Molecules

  • Ceramide NP (N-stearoyl phytosphingosine)C34H67NO4 · 553.9 g/mol

Genes / proteins

How could this ingredient interact with biology?

Biological network

Ingredient → molecule → target → gene/protein → pathway → process → studied outcome. Relationship strength is drawn from the curated confidence tier; nothing is added to make the chain look complete.

100%
Ceramide NPCeramide NP (N-stearoyl p…Ceramide synthase 3 (CERS…ABCA12 lipid transporterCERS3ABCA12Sphingolipid metabolismFormation of the cornifie…Epidermal barrier formati…Transepidermal water loss…Studied for barrier repai…

drag to pan · hover to isolate a path · click a node for detail

IngredientMoleculeTargetGenePathwayProcessOutcome

1 lower-confidence relationship is hidden at this filter level. Use “Show more biology” to include them.

Text alternative for this network
  • Ceramide NP is molecule Ceramide NP (N-stearoyl phytosphingosine)high confidence
  • Ceramide NP (N-stearoyl phytosphingosine) associated with Ceramide synthase 3 (CERS3)medium confidence
  • Ceramide NP (N-stearoyl phytosphingosine) associated with ABCA12 lipid transportermedium confidence
  • Ceramide synthase 3 (CERS3) encoded by CERS3medium confidence
  • ABCA12 lipid transporter encoded by ABCA12medium confidence
  • CERS3 participates in Sphingolipid metabolismmedium confidence
  • ABCA12 participates in Sphingolipid metabolismmedium confidence
  • CERS3 participates in Formation of the cornified envelopemedium confidence
  • ABCA12 participates in Formation of the cornified envelopemedium confidence
  • Sphingolipid metabolism associated with Epidermal barrier formationhigh confidence
  • Formation of the cornified envelope associated with Epidermal barrier formationmedium confidence
  • Sphingolipid metabolism associated with Transepidermal water loss regulationmedium confidence
  • Formation of the cornified envelope associated with Transepidermal water loss regulationmedium confidence
  • Epidermal barrier formation studied in Studied for barrier repair and dryness endpointsmedium confidence
  • Transepidermal water loss regulation studied in Studied for barrier repair and dryness endpointsmedium confidence

Biological pathways

Sphingolipid metabolism

high confidence

Ceramide synthesis and turnover in keratinocytes.

Reactome R-HSA-428157

Formation of the cornified envelope

medium confidence

Lipid lamellae assembly during terminal differentiation.

Reactome R-HSA-6809371

Evidence engine

Moderate

Some human evidence exists, but replication or sample sizes are limited.

Skinceptor Evidence Index

47

experimental · of 100

This index is a research-navigation aid describing how much evidence exists and how it was produced. It is not a medical safety score, an efficacy guarantee, or a clinical recommendation.

Study composition

  • Randomised controlled trial1
  • Animal1
  • In-vitro1
  • Review2
Total studies
5
Human studies
1
Largest sample
60
Range
1996–2017

Index breakdown

  • Study design quality48% × 28%

    Mean design weight across curated studies (meta-analysis 1.0, RCT 0.9, other human 0.7, review 0.45, animal 0.35, in-vitro 0.25).

  • Human evidence share33% × 22%

    Proportion of curated evidence measured in people rather than cells or animals.

  • Evidence volume82% × 14%

    Log-scaled count of curated studies, so volume alone cannot dominate the score.

  • Largest sample size59% × 12%

    Log-scaled largest reported sample size across curated human studies.

  • Replication33% × 12%

    Independent human studies, capped at three; one study is never treated as replicated.

  • Recency55% × 7%

    Linear decay over a twenty-year window from the most recent curated publication.

  • Source traceability0% × 5%

    Share of curated studies with a verified PMID or DOI in this dataset.

How is this determined? →

Insufficient comparable evidence for quantitative synthesis.

Research timeline

How the evidence accumulated

  1. 1996

    Physiological lipid mixtures and accelerated barrier recovery

    Animalsample size unavailable · Archives of Dermatological Research

  2. 2000

    Topical niacinamide and epidermal barrier lipid synthesis in cultured keratinocytes

    In-vitrosample size unavailable · Journal of Cosmetic Science

  3. 2003

    Stratum corneum lipids and barrier function: ceramide, cholesterol and free fatty acid ratios

    Reviewsample size unavailable · Journal of Lipid Research (review)

  4. 2016

    Essential fatty acid deficiency and epidermal acylceramide formation

    Reviewsample size unavailable · Journal of Lipid Research (review)

  5. 2017

    Ceramide-containing moisturiser and barrier recovery in dry skin

    Randomised controlled trialn = 60 · Journal of Cosmetic Dermatology

Ingredient fingerprint

12 nodes · 18 relationships · seed "ceramide-np"

The fingerprint is a deterministic visual signature: ridge amplitude comes from the number of entities in each tier, node placement from identifier hashes, and opacity from confidence. Two ingredients can never produce the same figure unless their networks are identical.

Open in Biology as Art →

Research

5 curated studies

Randomised controlled trialJournal of Cosmetic Dermatology · 2017n = 60

Ceramide-containing moisturiser and barrier recovery in dry skin

Reported faster transepidermal water loss recovery with a ceramide-dominant formulation compared with a control emollient.

LimitationsShort duration; identifier not verified during curation.

ReviewJournal of Lipid Research (review) · 2016

Essential fatty acid deficiency and epidermal acylceramide formation

Establishes linoleate as required for omega-O-acylceramide formation, with PNPLA1 mediating the transfer step.

LimitationsReview of genetic and animal evidence; topical repletion effects less characterised.

ReviewJournal of Lipid Research (review) · 2003

Stratum corneum lipids and barrier function: ceramide, cholesterol and free fatty acid ratios

Establishes the approximately equimolar ceramide/cholesterol/free fatty acid composition required for competent lamellar barrier structure.

LimitationsReview; ratio requirements derived largely from animal and ex-vivo models.

Identifier not curated — search Europe PMCCeramide NP · Cholesterol · Linoleic acid
In-vitroJournal of Cosmetic Science · 2000

Topical niacinamide and epidermal barrier lipid synthesis in cultured keratinocytes

Reported increased ceramide and free fatty acid synthesis in keratinocyte culture after niacinamide exposure.

LimitationsIn-vitro only; concentrations may not reflect in-use exposure.

AnimalArchives of Dermatological Research · 1996

Physiological lipid mixtures and accelerated barrier recovery

Reported that only balanced ceramide/cholesterol/fatty acid mixtures accelerated barrier recovery; incomplete mixtures delayed it.

LimitationsAnimal model; identifier not verified during curation.

Identifier not curated — search Europe PMCCholesterol · Ceramide NP · Linoleic acid

Community evidence

Submitted by readers

Submit a study

Reader submissions appear here only after review. They are not part of the curated dataset and do not affect the Skinceptor Evidence Index.

No approved community submissions yet.

Sources

Related biology maps